☆ 4.6 Review

Recent Developments in Human Papillomavirus (HPV) Vaccinology

VIRUSES-BASEL (2023)

Related references

Note: Only part of the references are listed.
Article Economics

Hospital resource utilisation from HPV-related diseases in England: a real-world cost analysis

G. Fabiano et al.

Summary: The study aimed to assess the economic burden of HPV-related diseases on hospital resources from the perspective of NHS in England. The findings revealed that the treatment of HPV-related diseases consumed a significant amount of resources in English hospitals, and these data can inform policy decisions to optimize the use of NHS resources.

EUROPEAN JOURNAL OF HEALTH ECONOMICS (2023)

Add to Collection
Article Medicine, Research & Experimental

The Efficacy of Human Papillomavirus Vaccination as an Adjuvant Therapy in Recurrent Respiratory Papillomatosis

Anusha Ponduri et al.

Summary: The efficacy of HPV vaccination as an adjuvant therapy in recurrent respiratory papillomatosis (RRP) was characterized through a systematic review and meta-analysis of 13 studies. The addition of HPV vaccination was associated with increased intervals between surgeries and decreased number of surgical procedures required. This suggests that HPV vaccination may be a beneficial adjuvant treatment for RRP.

LARYNGOSCOPE (2023)

Add to Collection
Review Medicine, General & Internal

Updates on HPV Vaccination

Ojone Illah et al.

Summary: Cervical cancer remains a significant global challenge, but developed countries have made progress with structured screening programs and HPV vaccination. In a few decades, countries with national HPV vaccination programs are on track for cervical cancer elimination. However, developing countries without these programs still face high rates of morbidity and mortality from cervical cancer. Increasing global HPV vaccine coverage and uptake is crucial for addressing the unequal distribution of cervical cancer incidence.

DIAGNOSTICS (2023)

Add to Collection
Article Immunology

Human Papillomavirus-associated Anal Cancer Incidence and Burden Among US Men, According to Sexual Orientation, Human Immunodeficiency Virus (HIV) Status, and Age

Ashish A. Deshmukh et al.

Summary: This study is the first to examine anal cancer incidence and burden among US men based on sexual orientation, HIV status, and age. The findings provide critical information for defining the screening-eligible population and informing prevention recommendations in different male risk groups.

CLINICAL INFECTIOUS DISEASES (2023)

Add to Collection
Article Oncology

Global burden of HPV-attributable squamous cell carcinoma of the anus in 2020, according to sex and HIV status: A worldwide analysis

Ashish A. Deshmukh et al.

Summary: Squamous cell carcinoma of the anus (SCCA), caused by HPV, has a higher incidence in persons living with HIV (PLWHIV). Globally, the number of female SCCA cases is twice that of males, with a higher burden in countries with a very high Human Development Index (HDI). Approximately 21% of male SCCA cases globally occur in PLWHIV, while only about 3% of female SCCA cases occur in this population.

INTERNATIONAL JOURNAL OF CANCER (2023)

Add to Collection
Article Immunology

Updated estimate of the annual direct medical cost of screening and treatment for human papillomavirus associated disease in the United States

Patrick A. Clay et al.

Summary: The annual direct medical cost of HPV in the United States from 2014 to 2018 was estimated to be $9.01 billion, with 55% for cervical cancer screening, 43.8% for HPV-attributable cancer treatment, and less than 2% for treating anogenital warts and RRP. The updated estimate is slightly lower than the previous one, but it would have been significantly lower without the inclusion of higher cancer treatment costs.

VACCINE (2023)

Add to Collection
Article Immunology

Recurrent Respiratory Papillomatosis (RRP)-Meta-analyses on the use of the HPV vaccine as adjuvant therapy

Peter Goon et al.

Summary: Recurrent Respiratory Papillomatosis (RRP) is a rare and debilitating disease. Surgical treatment is the existing option, and there has been skepticism regarding the therapeutic benefits of prophylactic HPV vaccines. This meta-analysis of HPV vaccination alongside surgery demonstrates a reduction in recurrences or surgeries per month, suggesting that HPV vaccine can serve as a beneficial adjunct therapy to surgery.

NPJ VACCINES (2023)

Add to Collection
Review Public, Environmental & Occupational Health

Gender neutral HPV vaccination programs: Reconsidering policies to expand cancer prevention globally

J. Andrew Dykens et al.

Summary: Human papillomavirus (HPV) infection is a major cause of cancer, including cervical cancer, and prevention efforts such as HPV vaccination are crucial. However, many countries still have low vaccine coverage rates, hindering the elimination of cervical cancer. Implementing gender-neutral HPV vaccination programs can help reduce infections, combat misinformation, and promote gender equality. Research and understanding of stakeholders' perspectives is necessary to develop effective policies and programs to overcome barriers and improve vaccine uptake.

FRONTIERS IN PUBLIC HEALTH (2023)

Add to Collection
Article Oncology

Impact of a Human Papillomavirus Vaccination Program within Organized Cervical Cancer Screening: Cohort Study

Cecilia Acuti Martellucci et al.

Summary: In a study conducted in central Italy, catch-up HPV vaccination was found to significantly reduce the risk of cervical abnormalities detected in organized screening and provide herd protection to unvaccinated women.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)

Add to Collection
Article Immunology

Proportion of Incident Genital Human Papillomavirus Detections not Attributable to Transmission and Potentially Attributable to Latent Infections: Implications for Cervical Cancer Screening

Talia Malagon et al.

Summary: This study investigates the reactivation of latent HPV infections and finds that a significant proportion of newly detected HPV infections are actually reactivations of previous infections rather than recent transmissions. This finding is important for cervical cancer screening in women.

CLINICAL INFECTIOUS DISEASES (2022)

Add to Collection
Article Immunology

Impact of the human papillomavirus (HPV) vaccine supply shortage on Tanzania's national HPV vaccine introduction

Anyie J. Li et al.

VACCINE (2022)

Add to Collection
Article Oncology

Age-specific burden of cervical cancer associated with HIV: A global analysis with a focus on sub-Saharan Africa

Ahmadaye Ibrahim Khalil et al.

Summary: HIV substantially worsens HPV carcinogenicity and contributes to excess cervical cancer cases, especially in sub-Saharan Africa. Quantifying cervical cancer burden by age and HIV status can inform prevention efforts in this region. HIV has a greater impact on younger women and HIV-attributable cases tend to shift towards younger age groups.

INTERNATIONAL JOURNAL OF CANCER (2022)

Add to Collection
Article Health Care Sciences & Services

Evaluating Risk-Stratified HPV Catch-up Vaccination Strategies: Should We Go beyond Age 26?

Fan Wang et al.

Summary: The study found that catch-up vaccines are still beneficial for all women after age 26 from the perspective of clinical outcomes. Women at high risk of HPV infection are expected to gain more health benefits compared to those with low HPV risk.

MEDICAL DECISION MAKING (2022)

Add to Collection
Review Immunology

HPV Vaccination after Primary Treatment of HPV-Related Disease across Different Organ Sites: A Multidisciplinary Comprehensive Review and Meta-Analysis

Violante Di Donato et al.

Summary: This study assessed the efficacy of adjuvant HPV vaccination on reducing the risk of recurrence in HPV-related diseases. The results showed that adjuvant vaccination decreased the recurrence rates of various diseases. Further research is needed.

VACCINES (2022)

Add to Collection
Review Obstetrics & Gynecology

Human papillomavirus vaccination in women undergoing excisional treatment for cervical intraepithelial neoplasia and subsequent risk of recurrence: A systematic review and meta-analysis

Dina Overgaard Eriksen et al.

Summary: This review and meta-analysis aimed to investigate the association between human papilloma virus (HPV) vaccination administered after excisional treatment of cervical intraepithelial neoplasia (CIN) and the risk of CIN grade 2 or worse (CIN2+) recurrence. The analysis included nine studies and found that post-treatment HPV vaccination was associated with a significantly reduced risk of CIN2+ recurrence. However, there were serious risks of bias in the included studies.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2022)

Add to Collection
Editorial Material Medicine, General & Internal

Long-Term Effectiveness of Human Papillomavirus Vaccination: Implications for Future Reduction in Cancer

Rebecca B. Perkins et al.

ANNALS OF INTERNAL MEDICINE (2022)

Add to Collection
Article Oncology

The impact of catch-up bivalent human papillomavirus vaccination on cervical screening outcomes: an observational study from the English HPV primary screening pilot

Matejka Rebolj et al.

Summary: In England, a population-based catch-up campaign for bivalent HPV vaccination was carried out for girls aged 14-17, and these women are now undergoing the national cervical screening program. The study showed that catch-up bivalent vaccination significantly reduced the detection of high-grade cervical intraepithelial neoplasia (CIN2+) associated with HPV16/18, as well as the overall detection rate of CIN2+. The positive predictive value of colposcopy for CIN2+ also decreased for both low-grade and high-grade abnormalities on triage cytology. However, the impact on screening outcomes for women aged 26-29 was smaller.

BRITISH JOURNAL OF CANCER (2022)

Add to Collection
Article Oncology

Possible Reactivation of Latent Anal Human Papillomavirus Associated with Markers of Immune Dysfunction in Gay and Bisexual Men

I. Mary Poynten et al.

Summary: The incidence of high-risk anal human papillomavirus (HPV) is relatively common in sexually inactive gay and bisexual men, and is associated with increasing age and immune dysfunction, indicating potential reactivation of HPV.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)

Add to Collection
Article Immunology

Anal Cancer Screening and Prevention: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infection Guidelines

Luis F. Barroso et al.

Summary: This article summarizes the key questions, evidence, recommendations, and areas for further research in the screening, diagnosis, and prevention of anal cancer as discussed by the advisory group convened by CDC in June 2019.

CLINICAL INFECTIOUS DISEASES (2022)

Add to Collection
Article Otorhinolaryngology

Outcomes After Human Papillomavirus Vaccination in Patients With Recurrent Respiratory Papillomatosis A Nonrandomized Clinical Trial

Jana Smahelova et al.

Summary: This study evaluated the efficacy of HPV vaccination in patients with new and recurrent RRP. It found that HPV vaccination was associated with a lower number of recurrences requiring surgical intervention. The patients showed increased levels of HPV-specific antibodies after vaccination and had a reduced burden of disease. There was no difference in postvaccination recurrences between patients with newly diagnosed and recurrent RRP.

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2022)

Add to Collection
Article Immunology

Quadrivalent Human Papillomavirus Vaccine Effectiveness after 12 Years in Madrid (Spain)

Juan J. Hernandez-Aguado et al.

Summary: This study examines the effectiveness of the quadrivalent HPV vaccine in reducing HPV infection and cytologic abnormalities in Spain. The results indicate a significant reduction in infection rates and associated cytologic abnormalities in the vaccinated group.

VACCINES (2022)

Add to Collection
Review Microbiology

Viral Pathogens in Oesophageal and Gastric Cancer

Kishen Rajendra et al.

Summary: Tumour virology studies viral pathogens that cause cancer, with approximately 20% of human cancers having a viral etiology. Different viruses play roles at different stages of carcinogenesis and may require co-factors. Oesophageal and gastric malignancies are associated with multiple risk factors, including human papillomavirus (HPV), Epstein-Barr virus (EBV), and Helicobacter pylori (HP). Viral antigen expression in tumors offers potential for prevention and therapy, as demonstrated by successful vaccines for HPV and HBV.

PATHOGENS (2022)

Add to Collection
Article Virology

Oesophageal carcinoma: The prevalence of DNA tumour viruses and therapy

Sile Li et al.

Summary: Esophageal carcinoma is the sixth leading cause of cancer death, with low survival rates. Infection with oncogenic viruses, notably human papillomavirus (HPV), is suspected to play a significant role in the development of esophageal carcinoma. This review explores the association between oncogenic viruses and esophageal carcinoma, with a focus on HPV. The efficacy of various treatment regimens, including immunotherapy, chemotherapy, and chemoradiotherapy, is also discussed.

TUMOUR VIRUS RESEARCH (2022)

Add to Collection
Review Public, Environmental & Occupational Health

Cervical cancer prevention in countries with the highest HIV prevalence: a review of policies

Serra Lem Asangbeh-Kerman et al.

Summary: Considerable progress has been made in policy development for cervical cancer prevention and control in sub-Saharan Africa. However, in countries with a high HIV burden, there is a need to tailor these policies to respond to the specific needs of women living with HIV (WLHIV). Countries may consider updating policies using the recent WHO guidelines for cervical cancer prevention, while adapting them to context realities.

BMC PUBLIC HEALTH (2022)

Add to Collection
Article Medicine, General & Internal

Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer

J. M. Palefsky et al.

Summary: Treatment for anal HSIL can significantly reduce the risk of anal cancer in persons living with HIV.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection
Review Immunology

Prophylactic Human Papillomavirus Vaccination: From the Origin to the Current State

Ayazhan Akhatova et al.

Summary: Immunization is a highly successful method for preventing infectious diseases, including HPV infection. Multiple HPV vaccines have been developed and proven to be effective and safe. However, concerns and negative perceptions have hindered the implementation of HPV vaccination campaigns in some countries. Therefore, it is important to promote health education interventions to increase acceptance of HPV vaccines.

VACCINES (2022)

Add to Collection
Review Medicine, General & Internal

Role of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: systematic review and meta-analysis

Konstantinos S. Kechagias et al.

Summary: This study aimed to evaluate the efficacy of human papillomavirus (HPV) vaccination in reducing the risk of HPV infection and recurrent diseases related to HPV infection in individuals undergoing local surgical treatment. A systematic review and meta-analysis were conducted, and the findings suggested that vaccination could reduce the risk of recurrence of cervical intraepithelial neoplasia grade 2 or higher (CIN2+), particularly when related to HPV16 or HPV18. However, the quality of evidence was inconclusive, highlighting the need for large-scale, high-quality randomized controlled trials.

BMJ-BRITISH MEDICAL JOURNAL (2022)

Add to Collection
Article Environmental Sciences

The HIV Epidemic in South Africa: Key Findings from 2017 National Population-Based Survey

Khangelani Zuma et al.

Summary: South Africa has the highest number of people living with HIV worldwide. The fifth HIV prevalence, incidence, and behavior survey conducted in 2017 revealed that the HIV prevalence rate was 14.0%, with an estimated 7.9 million people living with HIV. The survey also highlighted ongoing risky behaviors among young people, such as early sexual debut and multiple sexual partnerships, indicating persistent challenges in behavior change.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Add to Collection
Article Public, Environmental & Occupational Health

Cost-effectiveness of a male catch-up human papillomavirus vaccination program in the Netherlands

Joost J. M. Simons et al.

Summary: The Health Council of the Netherlands recommends HPV vaccination for both boys and girls, and a catch-up program for males up to age 26. The study shows that vaccinating males can prevent a significant number of cancer cases with an acceptable cost-effectiveness ratio.

PREVENTIVE MEDICINE REPORTS (2022)

Add to Collection
Article Ophthalmology

Human papillomavirus-related neoplasia of the ocular adnexa

Ingvild Margrethe Sellaeg Ramberg

Summary: This study assessed the correlation between HPV and carcinomas arising in the mucosa of the ocular adnexal tissue and analyzed the clinical, histopathological, and genomic features of these tumors. The results showed that HPV is associated with a subset of conjunctival and lacrimal drainage system carcinomas, which share genomic and phenotypic characteristics with HPV-positive carcinomas of other anatomical locations.

ACTA OPHTHALMOLOGICA (2022)

Add to Collection
Article Immunology

Immunogenicity and safety of two novel human papillomavirus 4-and 9-valent vaccines in Chinese women aged 20-45 years: A randomized, blinded, controlled with Gardasil (type 6/11/16/18), phase III non-inferiority clinical trial

Yajun Shu et al.

Summary: This study demonstrates that the novel 4- and 9-valent HPV vaccines are non-inferior to Gardasil 4 in terms of immunogenicity and safety. The vaccines are highly immunogenic and well tolerated.

VACCINE (2022)

Add to Collection
Article Oncology

Increased prevalence of human papillomavirus in fresh tissue from penile cancers compared to non-malignant penile samples: a case-control study

Sinja Kristiansen et al.

Summary: This study found that the prevalence of HPV is significantly higher in penile cancer compared to non-malignant penile samples. HPV16 is the predominant type in penile tumors, and its expression is more common in penile cancer than in adjacent healthy tissue.

BMC CANCER (2022)

Add to Collection
Article Infectious Diseases

Human papillomavirus vaccination in the European Union/European Economic Area and globally: a moral dilemma

Edoardo Colzani et al.

Summary: While many EU/EEA countries have expanded HPV vaccination to boys, low and middle-income countries severely affected by HPV still face limited vaccine supply for girls. Global introduction of HPV vaccination is at 50%, with some LMICs with high cervical cancer burden lagging behind or having suboptimal coverage. WHO's call for cervical cancer elimination in 2018 is hindered by a predicted global shortage of HPV vaccines until at least 2024.

EUROSURVEILLANCE (2021)

Add to Collection
Article Biotechnology & Applied Microbiology

Public health impact and cost-effectiveness of catch-up 9-valent HPV vaccination of individuals through age 45 years in the United States

Vincent Daniels et al.

Summary: The study evaluated the public health impact and cost-effectiveness of expanding catch-up HPV vaccination up to age 45, showing that this expansion would prevent tens of thousands of cases of cancer and other diseases, with a favorable cost-effectiveness ratio.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

Add to Collection
Article Immunology

Significant Declines in Juvenile-onset Recurrent Respiratory Papillomatosis Following Human Papillomavirus (HPV) Vaccine Introduction in the United States

Elissa Meites et al.

Summary: Study findings suggest a significant decrease in the number of cases and incidence rates of Juvenile-onset Recurrent Respiratory Papillomatosis (JORRP) in the United States following the introduction of HPV vaccination. Data indicate that HPV vaccination plays a crucial role in reducing the incidence of JORRP.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection
Article Infectious Diseases

Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials

Filipe Colaro Mariz et al.

Summary: This study tracked the data from two international HPV vaccine trials in Finland, and found that HPV vaccine-induced antibodies can last up to 12 years after vaccination. Significant differences were observed in the neutralising antibody efficacy and cross-neutralising antibody efficacy between quadrivalent and bivalent vaccine recipients, which correlated with vaccine efficacy.

LANCET INFECTIOUS DISEASES (2021)

Add to Collection
Article Oncology

Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study

Partha Basu et al.

Summary: This study in India compared the efficacy of single dose HPV vaccine with two and three doses in protecting against persistent HPV 16 and 18 infection over a 10-year period. The research found that a single dose of the vaccine provided similar protection against these infections as two or three doses, which are responsible for nearly 70% of cervical cancers.

LANCET ONCOLOGY (2021)

Add to Collection
Review Immunology

Sex difference in the immunogenicity of the quadrivalent Human Papilloma Virus vaccine: Systematic review and meta-analysis

Lafi Aldakak et al.

Summary: This study revealed that females have higher antibody titers against Human Papilloma Virus (HPV) after receiving the quadrivalent HPV vaccine compared to males, particularly in low-risk HPV strains. Adjusting vaccine doses and schedules based on sex should be further explored.

VACCINE (2021)

Add to Collection
Article Virology

Misclassifications in human papillomavirus databases

Laila Sara Arroyo Muhr et al.

Summary: By analyzing 25,638 HPV sequences in GenBank, 110 sequences with taxonomy/naming errors and 1318 possible chimeric sequences were identified. Among them, 114 were chimeras and 13 had taxonomy/naming errors. Around 800 unique putative HPV types were found in GenBank.

VIROLOGY (2021)

Add to Collection
Article Public, Environmental & Occupational Health

Estimates of the global burden of cervical cancer associated with HIV

Dominik Stelzle et al.

Summary: HIV infection significantly increases the risk of cervical cancer, especially in countries in southern Africa and eastern Africa. The burden of HIV-attributable cervical cancer is substantial, with a significant proportion of new cases diagnosed among women living with HIV.

LANCET GLOBAL HEALTH (2021)

Add to Collection
Review Oncology

Human Papilloma Virus vaccine and prevention of head and neck cancer, what is the current evidence?

Giovanni Diana et al.

Summary: Studies have shown that HPV vaccination has some effectiveness in preventing head and neck cancer, with an estimated population-level effect of 17.0% due to low vaccine coverage. Further research is needed to confirm the causal relationship between vaccination and prevention of oral infection, as well as to investigate the duration of vaccine efficacy.

ORAL ONCOLOGY (2021)

Add to Collection
Article Oncology

Worldwide trends in cervical cancer incidence and mortality, with predictions for the next 15 years

Shujuan Lin et al.

Summary: Cervical cancer burden is correlated with socioeconomic development, with most countries showing stable or decreasing trends in incidence and mortality rates, especially in those with effective screening programs and HPV vaccination. Predicted trends for the next 15 years were consistent with observed trends among analyzed countries.

CANCER (2021)

Add to Collection
Review Primary Health Care

Human Papillomavirus-Associated Head and Neck Cancer

Juan C. Nogues et al.

Summary: Historically, tobacco and alcohol were the main causes of oropharyngeal squamous cell carcinoma, but in recent decades, HPV infection has become the leading cause. HPV-positive OPSCC differs from HPV-negative disease in epidemiology, prognosis, treatment, and prevention. Lack of awareness and low vaccination rates make primary care providers crucial in prevention and early diagnosis.

JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2021)

Add to Collection
Article Infectious Diseases

Effect on genital warts in Australian female and heterosexual male individuals after introduction of the national human papillomavirus gender-neutral vaccination programme: an analysis of national sentinel surveillance data from

Eric P. F. Chow et al.

Summary: This is a copyright notice stating that the copyright belongs to Elsevier Ltd.

LANCET INFECTIOUS DISEASES (2021)

Add to Collection
Article Medicine, General & Internal

Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trial

Penelope Gray et al.

Summary: This study found that under moderate vaccination coverage, a gender-neutral vaccination strategy can achieve herd effect against HPV16/18. Compared to girls-only vaccination, gender-neutral vaccination strategy is more effective in achieving herd effect.

PLOS MEDICINE (2021)

Add to Collection
Article Immunology

Genotype Distribution Change After Human Papillomavirus Vaccination in Two Autonomous Communities in Spain

Javier Freire-Salinas et al.

Summary: This study reviewed the distribution of HPV genotypes in two autonomous communities in Spain after the introduction of HPV vaccination programs, finding a significant decrease in some genotypes but also observing replacement phenomenon with genotypes not included in the vaccines. Continued surveillance is needed to monitor any changes in genotype distribution over time.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Add to Collection
Article Infectious Diseases

Juvenile-Onset Recurrent Respiratory Papillomatosis in the United States, Epidemiology and HPV Types-2015-2020

Raiza Amiling et al.

Summary: This study found that children with JORRP were commonly firstborn, delivered vaginally to young mothers, and most of the mothers reported no HPV vaccination before delivery. Disease severity was associated with younger diagnosis age and detection of HPV type 11.

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2021)

Add to Collection
Article Oncology

Human Papillomavirus Vaccination After COVID-19

Zheng Quan Toh et al.

Summary: The COVID-19 pandemic threatens the uptake of HPV vaccination in low- and lower-middle income countries, impacting the WHO strategy for cervical cancer elimination. To achieve high HPV vaccination rates, increased global financial investment, improved vaccine supply, acceleration of single-dose schedules, education and social marketing, and universal school-based delivery are needed. Implementing these strategies will support the effective elimination of cervical cancer.

JNCI CANCER SPECTRUM (2021)

Add to Collection
Editorial Material Oncology

World Health Organization call for action to eliminate cervical cancer globally

Murat Gultekin et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)

Add to Collection
Article Dermatology

Nonavalent human papillomavirus vaccination as alternative treatment for genital warts

Simon Bossart et al.

DERMATOLOGIC THERAPY (2020)

Add to Collection
Article Immunology

Effectiveness of 'catch-up' human papillomavirus vaccination to prevent cervical neoplasia in immunosuppressed and non-immunosuppressed women

Michael J. Silverberg et al.

VACCINE (2020)

Add to Collection
Article Immunology

Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccines

Sabrina H. Tsang et al.

VACCINE (2020)

Add to Collection
Article Public, Environmental & Occupational Health

Quadrivalent human papillomavirus vaccination successfully reduces the prevalence of vaccine-targeted genotypes in a young, vaccine-eligible-age sample of Australian females

Asvini K. Subasinghe et al.

SEXUAL HEALTH (2020)

Add to Collection
Article Virology

IPVS statement on Temporary HPV vaccine shortage: Implications globally to achieve equity

Suzanne M. Garland et al.

PAPILLOMAVIRUS RESEARCH (2020)

Add to Collection
Article Immunology

Long-term Antibody Response to Human Papillomavirus Vaccines: Up to 12 Years of Follow-up in the Finnish Maternity Cohort

Hanna Artemchuk et al.

JOURNAL OF INFECTIOUS DISEASES (2019)

Add to Collection
Review Immunology

Residual or Recurrent Precancerous Lesions After Treatment of Cervical Lesions in Human Immunodeficiency Virus-infected Women: A Systematic Review and Meta-analysis of Treatment Failure

Pierre Debeaudrap et al.

CLINICAL INFECTIOUS DISEASES (2019)

Add to Collection
Article Biotechnology & Applied Microbiology

ICTV Virus Taxonomy Profile: Togaviridae

Rubing Chen et al.

JOURNAL OF GENERAL VIROLOGY (2018)

Add to Collection
Article Infectious Diseases

Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis

Chunqing Lin et al.

LANCET INFECTIOUS DISEASES (2018)

Add to Collection
Review Oncology

HPV vaccines - A review of the first decade

Diane M. Harper et al.

GYNECOLOGIC ONCOLOGY (2017)

Add to Collection
Review Biotechnology & Applied Microbiology

Expanded strain coverage for a highly successful public health tool: Prophylactic 9-valent human papillomavirus vaccine

Zhigang Zhang et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)

Add to Collection
Article Immunology

Transmission networks and risk of HIV infection in KwaZulu-Natal, South Africa: a community-wide phylogenetic study

Tulio de Oliveira et al.

LANCET HIV (2017)

Add to Collection
Review Biotechnology & Applied Microbiology

Use of the live attenuated Japanese Encephalitis vaccine SA 14-14-2 in children: A review of safety and tolerability studies

Amy Sarah Ginsburg et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)

Add to Collection
Article Immunology

Effect of HIV Infection on Human Papillomavirus Types Causing Invasive Cervical Cancer in Africa

Gary M. Clifford et al.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2016)

Add to Collection
Review Medicine, Research & Experimental

The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer

Zhen Gooi et al.

LARYNGOSCOPE (2016)

Add to Collection
Article Oncology

A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil

Jessica L. Castilho et al.

BMC CANCER (2015)

Add to Collection
Article Infectious Diseases

Human papillomavirus prevalence in South African women and men according to age and human immunodeficiency virus status

Zizipho Z. A. Mbulawa et al.

BMC INFECTIOUS DISEASES (2015)

Add to Collection
Article Oncology

A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer

Donna M. Graham et al.

CANCER (2015)

Add to Collection
Article Oncology

Unique Human Papillomavirus-Type Distribution in South African Women With Invasive Cervical Cancer and the Effect of Human Immunodeficiency Virus Infection

Matthys Cornelis van Aardt et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2015)

Add to Collection
Article Obstetrics & Gynecology

Cancer of the cervix: Early detection and cost-effective solutions

Lynette Denny et al.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2015)

Add to Collection
Article Oncology

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials

Aimee R. Kreimer et al.

LANCET ONCOLOGY (2015)

Add to Collection
Article Oncology

Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa

Lynette Denny et al.

INTERNATIONAL JOURNAL OF CANCER (2014)

Add to Collection
Article Infectious Diseases

High-risk human papillomavirus viral load and persistence among heterosexual HIV-negative and HIV-positive men

Mary K. Grabowski et al.

SEXUALLY TRANSMITTED INFECTIONS (2014)

Add to Collection
Article Oncology

Estimate of the global burden of cervical adenocarcinoma and potential impact of prophylactic human papillomavirus vaccination

Jeanne M. Pimenta et al.

BMC CANCER (2013)

Add to Collection
Article Oncology

Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial

Mahboobeh Safaeian et al.

CANCER PREVENTION RESEARCH (2013)

Add to Collection
Article Infectious Diseases

Significant Decrease in the Incidence of Genital Warts in Young Danish Women After Implementation of a National Human Papillomavirus Vaccination Program

Louise Baandrup et al.

SEXUALLY TRANSMITTED DISEASES (2013)

Add to Collection
Review Infectious Diseases

Association of genital human papillomavirus infection with HIV acquisition: a systematic review and meta-analysis

Pascale Lissouba et al.

SEXUALLY TRANSMITTED INFECTIONS (2013)

Add to Collection
Review Immunology

Global Burden of Human Papillomavirus and Related Diseases

David Forman et al.

VACCINE (2012)

Add to Collection
Article Virology

Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments

Hans-Ulrich Bernard et al.

VIROLOGY (2010)

Add to Collection
Article Immunology

Genital Human Papillomavirus Prevalence and Human Papillomavirus Concordance in Heterosexual Couples Are Positively Associated with Human Immunodeficiency Virus Coinfection

Zizipho Z. A. Mbulawa et al.

JOURNAL OF INFECTIOUS DISEASES (2009)

Add to Collection
News Item Oncology

A review of human carcinogens-Part B: biological agents

Veronique Bouvard et al.

LANCET ONCOLOGY (2009)

Add to Collection
Article Virology

Cervical and oral human papillomavirus types in HIV-1 positive and negative women with cervical disease in south Africa

Dianne J. Marais et al.

JOURNAL OF MEDICAL VIROLOGY (2008)

Add to Collection
Article Immunology

An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results

John T. Schiller et al.

VACCINE (2008)

Add to Collection
Article Medicine, General & Internal

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women:: an interim analysis of a phase III double-blind, randomised controlled trial

Jorma Paavonen et al.

LANCET (2007)

Add to Collection
Article Medicine, General & Internal

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

Elmar A. Joura et al.

LANCET (2007)

Add to Collection
Article Medicine, General & Internal

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

Suzanne M. Garland et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Add to Collection
Review Oncology

The global health burden of infection -associated cancers in the year 2002

Donald Maxwell Parkin

INTERNATIONAL JOURNAL OF CANCER (2006)

Add to Collection
Article Medicine, General & Internal

Sustained efficacy up to 4-5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

DM Harper et al.

LANCET (2006)

Add to Collection
Article Oncology

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

LL Villa et al.

LANCET ONCOLOGY (2005)

Add to Collection
Article Medicine, General & Internal

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

DM Harper et al.

LANCET (2004)

Add to Collection
Review Virology

Classification of papillomaviruses

EM de Villiers et al.

VIROLOGY (2004)

Add to Collection
Article Oncology

Human papillomavirus types in invasive cervical cancer worldwide:: a meta-analysis

GM Clifford et al.

BRITISH JOURNAL OF CANCER (2003)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.